Sperm donor screening for IVF checks defined infectious-disease risks and may also include medical history, semen evaluation, genetic review, and counseling. It does not test for every disease, guarantee future health, or predict whether IVF will produce embryos or a live birth.
The most important question is not “Was the donor screened?” Ask what was screened, when it was done, which rules applied, and what the fertility clinic still needs to review.
“Screening” covers several different tasks
Priya and Marco found a donor profile marked “fully screened.” They assumed that meant every infection and inherited condition had been excluded. Their clinic separated the file into four parts.
| Part of the review | What it generally asks |
|---|---|
| Donor eligibility | Does the donor meet federal requirements related to relevant communicable-disease risk? |
| Laboratory testing | Were the required infectious-disease tests performed with the right test and timing? |
| Program and clinic review | What medical history, physical exam, semen assessment, genetics, and counseling were added? |
| Recipient-specific review | Do the donor’s records fit the egg provider, clinic method, and intended parents’ plan? |
Those parts overlap, but they are not interchangeable. A bank’s approval does not replace the receiving clinic’s review.
What FDA-required donor testing addresses
FDA regulates donated reproductive tissue, including sperm. Its donor rules are designed to reduce the risk of transmitting relevant communicable diseases.
The FDA testing page lists core tests for HCT/P donors, including HIV-1, HIV-2, hepatitis B, hepatitis C, and syphilis. It also lists West Nile virus testing for living donors. Category-specific rules address HTLV-I and HTLV-II and cytomegalovirus for viable, leukocyte-rich tissue. Donors of reproductive HCT/Ps must also be tested for Chlamydia trachomatis and Neisseria gonorrhoeae unless an exception applies.
Exact assays, timing, specimen handling, eligibility findings, and exceptions are technical. They should be confirmed by the sperm bank and clinic. FDA also notes that testing recommendations may change as science and technology change.
Priya and Marco asked the bank for the donor-eligibility summary and test dates. They did not try to interpret raw lab values on their own.
Screening questions are different from blood tests
Federal donor eligibility also uses a medical-record review and screening for risk factors. A questionnaire or interview may cover health history, travel, exposure, procedures, sexual history, substance use, and other facts tied to communicable-disease risk.
A laboratory result shows whether a marker was found in a specimen at a point in time. A screening history helps assess risks that a single test may not fully show. Neither one creates zero risk.
For nondirected sperm donation, quarantine and repeat testing may apply. Directed donors follow federal and clinic rules that differ in important ways. ASRM’s 2024 guidance recommends additional steps for directed donation, including repeat infectious-disease testing after a shorter quarantine period, as well as genetics, counseling, and legal consultation.
Read Known Sperm Donor Agreements before treating a friend’s recent lab report as a complete directed-donor process.
Genetic screening is not one universal panel
ASRM recommends genetic risk assessment as part of donor care, but panels differ. One donor may have a small targeted panel. Another may have broad carrier screening. A report may have been produced years before the egg provider’s report.
Priya carried a recessive condition. The donor profile said “negative genetic screen,” but the donor had not been tested for the same gene. Their genetics professional explained the options and limits. The bank’s green badge was not enough to compare two people.
Ask for:
- The laboratory name.
- The test date.
- The full gene or condition list.
- The exact report, not only a profile summary.
- The donor’s family-health history.
- Any updated interpretation since the test.
- The process for matching the result with the egg provider.
A negative carrier screen reduces uncertainty only for the conditions and variants the test can detect. It cannot rule out every inherited condition, new mutation, chromosome issue, developmental difference, or future illness.
Semen testing answers another question
A semen analysis may measure volume, concentration, movement, and other features. Banks and clinics may also set post-thaw standards for different vial types.
These results help a laboratory decide whether a specimen fits IUI, conventional IVF, or ICSI. They do not guarantee fertilization, embryo development, pregnancy, or birth.
Priya and Marco’s clinic approved the donor but requested a specific vial type for ICSI. That was a lab-use decision, not a judgment about the donor as a person. Learn more in How Many Vials of Donor Sperm for IVF?.
What sperm donor screening does not tell you
Even a careful program cannot tell you:
- every current or future health condition;
- every genetic variant that could matter;
- whether all family history is complete or accurate;
- how a child’s personality, interests, height, or appearance will develop;
- whether a donor will respond to future contact;
- whether more vials will remain available;
- whether an IVF cycle will create usable embryos; or
- whether an embryo transfer will lead to a live birth.
Screening is a risk-reduction and information process. It is not a quality ranking or warranty.
The records checklist
Before the clinic clears the donor, ask whether your file includes:
- Donor-eligibility status and summary of records.
- Infectious-disease test names, dates, and results.
- Medical and family-history questionnaire.
- Physical examination information when required.
- Semen-analysis or post-thaw specifications relevant to the lab.
- Full genetic test report and genetics notes.
- Counseling completion when recommended.
- Directed-donor legal clearance when applicable.
- Clinic acceptance of the bank and vial type.
- A written process for future medical updates.
Keep copies. If donor sperm will be used to create embryos for a carrier, connect these records to the wider plan in Donor Sperm and Surrogacy.
Practical questions for the bank and clinic
Ask the sperm bank:
- Which FDA donor rules applied to this specimen?
- When were the required tests performed and repeated?
- What medical and genetic review did your program add?
- How are new donor or offspring medical reports assessed and shared?
- Has any test interpretation or donor status changed?
Ask the clinic:
- Have you reviewed the complete donor file?
- Does the genetic panel align with the egg provider’s panel?
- Which gaps need counseling, testing, or informed consent?
- Is the exact vial type acceptable for our IVF plan?
- What records must arrive before the specimen or treatment cycle?
Use How to Choose a Sperm Donor to place the medical review beside identity and family decisions.
FAQs
Does a negative infectious-disease test mean there is no risk?
No. Tests have timing limits and technical limits. Screening also depends on the information available. FDA requirements are meant to reduce relevant communicable-disease risk, not erase all risk.
Are all sperm donors tested for the same genetic conditions?
No. Panels vary by program, laboratory, date, ancestry approach, and clinic policy. Request the actual report and ask a qualified genetics professional to compare it with the egg provider’s information.
Does donor screening predict IVF success?
No. Donor eligibility, semen quality, egg factors, laboratory methods, embryo development, and transfer outcomes are different issues. The clinic should explain which facts affect your specific treatment plan.
Does a known donor avoid FDA screening?
Directed donors are not a shortcut around clinical review. Federal rules, labeling and consent rules, clinic policies, and ASRM recommendations still matter. Ask the clinic and licensed counsel what applies before collection or treatment.
Is a semen analysis the same as donor screening?
No. A semen analysis describes features of the sample that may guide lab use. It does not replace donor-eligibility review, infectious-disease testing, medical history, or genetic risk assessment.